Streetbeat News

Earnings

JRVR

James River Group Holdings (NASDAQ: JRVR) reported Q2 2024 adjusted EPS of $0.33, missing the $0.42 estimate. Sales were $163.193M, below the $189.200M estimate. Despite the misses, EPS increased by 83.33% year-over-year, while sales decreased by 5.92%.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 8:31 pm

ANAB

AnaptysBio (NASDAQ:ANAB) reported Q2 2024 adjusted EPS of $(1.71), missing the $(0.89) estimate by 92.13%. Sales were $11.00M, missing the $24.30M estimate by 54.73%. Despite the misses, sales increased by 217.92% from $3.46M last year.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 8:30 pm

UTI

Universal Technical Institute (UTI) has unveiled the second phase of its North Star Strategy, which is expected to deliver approximately 10% revenue CAGR and expand its Adjusted EBITDA margin to nearly 20% through fiscal 2029. The company has shown significant growth in revenue and adjusted EBITDA from fiscal year 2019 to fiscal year 2024.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 8:30 pm

STRL

Sterling Infrastructure (NASDAQ:STRL) reported Q2 2024 GAAP EPS of $1.67, beating the estimate of $1.42. Sales were $582.822M, surpassing the $563.233M estimate and showing an 11.58% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 8:30 pm

PLTR

Palantir has raised its revenue guidance for FY24 to between $2.742 billion and $2.75 billion, surpassing the previous estimate of $2.7 billion. The company also increased its US commercial revenue guidance to over $672 million, indicating a growth rate of at least 47%. Additionally, Palantir raised its adjusted income from operations guidance to between $966 million and $974 million, while maintaining expectations for adjusted free cash flow of $800 million to $1 billion and GAAP operating income and net income in each quarter of the year.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 8:30 pm

AHR

American Healthcares (NYSE:AHR) reported Q2 2024 earnings per share of $0.33, beating the analyst estimate of $0.29 by 13.79%. However, the company's sales of $504.581 million missed the estimate of $507.744 million by 0.62%. This represents a 7.92% increase over the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 8:29 pm

KIDS

OrthoPediatrics (NASDAQ:KIDS) reported Q2 2024 adjusted EPS of $(0.23), beating the estimate of $(0.27). Sales were $52.802M, surpassing the $52.495M estimate and marking a 33.48% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 8:28 pm

AIMD

Ainos shares are trading lower after the company reported a year-over-year decrease in Q2 revenue results.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 8:28 pm

AIMD

Ainos reported Q2 revenue of $0, a significant drop from $28,555 year-over-year.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 8:27 pm

VNO

Vornado Realty (NYSE:VNO) reported Q2 2024 earnings per share (EPS) of $0.57, beating the analyst estimate of $0.54. Sales were $450.266 million, also surpassing the estimate of $439.277 million. However, both EPS and sales were down compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 8:27 pm